AEP
54
6
SNA
70
-5
PEG
62
4
DVN
14
-6
SBUX
37
-2
CAG
24
-3
GOOG
57
-6
FSLR
44
-2
CINF
53
3
URI
60
-6
NEM
40
3
GLW
45
-3
SEE
53
3
JNJ
41
3
TDC
67
-4
ILMN
32
-9
CI
45
-3
ISRG
71
-5
ADM
28
3
D
40
2
AEP
54
6
SNA
70
-5
PEG
62
4
DVN
14
-6
SBUX
37
-2
CAG
24
-3
GOOG
57
-6
FSLR
44
-2
CINF
53
3
URI
60
-6
NEM
40
3
GLW
45
-3
SEE
53
3
JNJ
41
3
TDC
67
-4
ILMN
32
-9
CI
45
-3
ISRG
71
-5
ADM
28
3
D
40
2
Financhill
Back

First Solar Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
44

FSLR
First Solar

Last Price:
190.29
Seasonality Move:
5.57%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
44
First Solar (FSLR) is a Sell

Is First Solar a Buy, Sell or Hold?

  • The current First Solar [FSLR] share price is $190.45. The Score for FSLR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FSLR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FSLR Stock Price Chart

What is First Solar's stock price today?

  • The First Solar share price today is $190.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FSLR is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.15 Sell
Relative Strength Index (14 RSI): 42.77 Sell
Chaikin Money Flow: -3892853 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.68 - 207.1) Sell
Bollinger Bands (100): (202.9 - 235.78) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 191.05 Sell
20-day SMA: 197.14 Sell
50-day SMA: 216.38 Sell
200-day SMA: 205.26 Sell
8-day EMA: 192.3 Sell
20-day EMA: 198.64 Sell
50-day EMA: 209.56 Sell
200-day EMA: 206.81 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Solar Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.46 per share, and an increase next year of $7.75 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Solar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):